| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016646 Osteogenic protein, matrix of nonsynthetic, nonpolymeric material and a binding agent |
| 08/23/2001 | US20010016645 Vitazin antibody; treating angiogenesis or restenosis |
| 08/23/2001 | US20010016644 Protein of given molecular weight and given N-terminal amino acid sequence |
| 08/23/2001 | US20010016643 Peptide derivatives |
| 08/23/2001 | US20010016600 Method of treating cancer using dithiocarbamate derivatives |
| 08/23/2001 | US20010016575 Antisense modulation of human MDM2 expression |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | US20010016569 Complexes |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore |
| 08/23/2001 | US20010016340 Antihemophilia agent |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016338 DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016333 Cancer diagnosis |
| 08/23/2001 | US20010016325 Activation of novel estrogen receptor supports and neuronal viability and function |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016214 Substance containing proteins and insoluble dietary fibers derived from the germinated seed of a grass family plant and uses thereof |
| 08/23/2001 | US20010016198 T cell receptor ligands and methods of using same |
| 08/23/2001 | US20010016196 Immunoliposomes that optimize internalization into target cells |
| 08/23/2001 | US20010016195 Cytokine antagonists for the treatment of localized disorders |
| 08/23/2001 | US20010016194 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 08/23/2001 | US20010016193 Methods of altering cardiac cell phenotype |
| 08/23/2001 | US20010016192 An expression vector of partial or total deletion of a protein DNA and a gene encoding a foreign protein; used as tumor suppressor genes |
| 08/23/2001 | US20010016191 Viewing informatoin, selecting a site for, and preparing a molecule of an alteration on a granulocyte colony-stimulating factor (g-csf) three dimensional molecule, and testing for desired characteristics; retain internal core helices |
| 08/23/2001 | EP1143808A3 Ingestible compositions comprising antibacterial agents |
| 08/23/2001 | DE10008128A1 Endoparasiticide composition effective on topical administration, comprises solution of depsipeptide in solvent such as 1,2-isopropylidene-glycerol |
| 08/23/2001 | DE10007468A1 Neues zentralnervöses Protein, das K·+·-Ströme moduliert New central nervous protein that modulates K · · + currents |
| 08/23/2001 | DE10006179A1 Neue Verwendung von Lungensurfactant zur Prophylaxe und Behandlung von chronischen Lungenerkrankungen Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic lung disease |
| 08/23/2001 | DE10006175A1 Isoform of neuregulin-beta with acidic isoelectric point, useful as indicator or target, e.g. in screening for potential neurological agents |
| 08/23/2001 | CA2405714A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | CA2405689A1 Vasoactive intestinal peptide analogs |
| 08/23/2001 | CA2402148A1 Novel sphingosine kinases |
| 08/23/2001 | CA2400981A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | CA2400627A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400473A1 Her-2 binding antagonists |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400355A1 Pancreatic islet cell growth factors |
| 08/23/2001 | CA2400342A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400274A1 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/23/2001 | CA2400263A1 Method of controlling telomere length |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2400101A1 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2399822A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | CA2399816A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | CA2399757A1 Polypeptoid pulmonary surfactants |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2399668A1 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 08/23/2001 | CA2399219A1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 08/23/2001 | CA2398945A1 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | CA2398825A1 Gtpase activating proteins |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2398395A1 Conjugates targeted to target receptors |
| 08/23/2001 | CA2396793A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | CA2395038A1 Matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2337574A1 Hematopoietic stem cell expansion enhancing factor and method of use |
| 08/22/2001 | EP1126029A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126027A1 Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 |
| 08/22/2001 | EP1126025A2 Oligonucleotide modulation of protein kinase C |
| 08/22/2001 | EP1125977A1 Dermatan sulfate composition as antithrombotic |
| 08/22/2001 | EP1125948A1 Monocyte chemotactic protein-4 |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1125946A1 Cell adhesion therapy through modulation of a Rap family member or of a GEF (guanine nucleotide exchange factor) |
| 08/22/2001 | EP1125938A1 Protein kinase inhibitors for treatment of neurological disorders |
| 08/22/2001 | EP1125585A1 Remedies for immunological diseases |
| 08/22/2001 | EP1125584A1 Betacellulin protein-containing preparations |
| 08/22/2001 | EP1125580A2 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 08/22/2001 | EP1125135A2 A complex of a chaperone with -amyloid and methods employing this complex |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124971A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 08/22/2001 | EP1124970A1 Process of purification of low density lipoprotein associated phospholipase a2 using immobilized metal affinity chromatography |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124965A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124964A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/22/2001 | EP1124961A2 Thrombopoietic compounds |
| 08/22/2001 | EP1124960A2 Activity dependent neurotrophic factor iii (adnf iii) |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |
| 08/22/2001 | EP1124956A2 Pharmaceutical composition, containing fragments of an antigenic protein encoding dna endowed with anti-tumor effect |
| 08/22/2001 | EP1124955A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
| 08/22/2001 | EP1124953A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 08/22/2001 | EP1124952A2 Therapeutic antiangiogenic endostatin compositions |
| 08/22/2001 | EP1124951A2 Human sorting nexins |
| 08/22/2001 | EP1124946A1 Glycosylated proteins having reduced allergenicity |
| 08/22/2001 | EP1124856A1 Conformation-specific anti-von willebrand factor antibodies |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124852A1 Lysine-rich statherin protein |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124847A1 Lhrh analogues for the treatment of osteoporosis |
| 08/22/2001 | EP1124846A2 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |